Likewise, in another prospective cohort study, ApoE4 carriers had a threefold increased risk of both AD and HSV-1 reactivation (i.e., as indicated by IgM seropositivity or elevated IgG levels) compared to ApoE4-negative individuals (Linard et al., 2020). Here, CD40LG is linked to Alzheimer disease.